Lipophilization of Resveratrol and Effects on Antioxidant Activities
作者:Won Young Oh、Fereidoon Shahidi
DOI:10.1021/acs.jafc.7b03129
日期:2017.10.4
lipophilicity of resveratrol and its alkyl esters was calculated using ALOGPS 2.1. Resveratrol exhibited greater antioxidant activity in both 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical cation scavenging assays. Resveratrol esters with long-chain fattyacids (C18:0 and C18:1) showed higher antioxidant activity in the DPPH radical scavenging
Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant
申请人:Maes Daniel H.
公开号:US20090035237A1
公开(公告)日:2009-02-05
An emulsion cosmetic composition comprising at least one resveratrol derivative, an aqueous phase, and an oil phase, having at least one silicone surfactant, and a method for preparing emulsions capable of delivering active resveratrol to the skin.
Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
申请人:Maes Daniel H.
公开号:US20090035240A1
公开(公告)日:2009-02-05
An aqueous based cosmetic composition comprising at least one resveratrol derivative and a water phase containing at least one aqueous phase structuring agent; or an emulsion composition comprising at least one water phase, at least one oil phase containing at least one nonvolatile silicone, and at least one resveratrol derivative.
Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
申请人:Flagship Pioneering Innovations V, Inc.
公开号:US10953027B2
公开(公告)日:2021-03-23
Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.